biotech stock review, dyadic

Must Watch Video: Dyadic’s (DYAI) Matthew Jones.

Click here to watch the video. It's the proverbial, "everything you wanted to know" about Cho cells. "We achieved encouraging results, knowledge and experience in...

Two Biotech Stocks on Takeover List?

Why These 2 Biotech Stocks Might Be Next On The Takeover List (IBD). Acadia Pharmaceuticals (ACAD) and Neurocrine Biosciences (NBIX) stand out as potential takeover candidates among biotech...
revelers.io

Low Carbs and AFIB?

Low-Carb Diets Could Increase Risk of Heart Rhythm (UK Independent). Popular low-carb diets promoted by celebrities including Gwyneth Paltrow and the Kardashians, as well as some doctors, could...

Dyadic (DYAI) Announces Effectiveness of Form 10 Registration Statement and Application to NASDAQ

JUPITER, FL / ACCESSWIRE / February 13, 2019 / Dyadic International, Inc. (the "Company") (OTCQX: DYAI) today announced that the Securities and Exchange Commission (the...
biotech stock review

Adding Mustang Bio (MBIO) $4.00 to Watchlist After Investor Presentation.

We met with management at Company-sponsored lunch at Ruth Chris in Boca Raton last week and we came away extremely enthusiastic about the Company's...
Dr. Lindsay Rosenwald

Dr Lindsay Rosenwald, Biography.

Wall Street Transcript Interview (2018) IDB Bank Profile Biography (2011) LR Facts*, below. For almost twenty years, Dr. Lindsay Rosenwald has been building a positive reputation within the...
biotech stock review

Orchestra BioMed™ Announces Completion of $41 Million Financing.

November 15, 2018 Capital proceeds to support late-stage clinical development of lead cardiovascular product candidates for artery disease and hypertensionFinancing structure provides for up to...

Immunomedics Chairman Buys $19 Million More in Stock.

(Barrons) Two weeks ago, B. Riley analyst Madhu Kumar gushed about Immunomedics, writing in a report that the biotech could have a “blockbuster cancer drug” in IMMU-132, an antibody-drug...

Latest article

Fusion Energy Starter.

VC-Funded Fusion Energy Companies "The fastest way to deploy fusion and I believe one of my forecasts is we will replace every coal and natural...

Party Time at UniQure (QURE)! From $8.86 to $47.21, up 432%.

I. No Bells, No Baskets. UniQure (QURE) $47 up Huge. Still Not Out Of The Woods! II. Replimune (REPL) $11.23. Gains 28% in Sympathy with...

We’re Up 360% in Six Weeks. Replimune (REPL).

That's a Gain of $604 Million, and That Ain't Bad! Six brokerage firms downgraded Replimune (REPL), around the same time we added it to...